No connection

Search Results

BLCO vs LNTH

BLCO
Bausch + Lomb Corporation
BEARISH
Price
$16.98
Market Cap
$6.01B
Sector
Healthcare
AI Confidence
85%
LNTH
Lantheus Holdings, Inc.
NEUTRAL
Price
$80.59
Market Cap
$5.25B
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
BLCO
--
LNTH
23.63
Forward P/E
BLCO
21.5
LNTH
12.81
P/B Ratio
BLCO
0.94
LNTH
4.78
P/S Ratio
BLCO
1.21
LNTH
3.4
EV/EBITDA
BLCO
19.71
LNTH
14.31

Profitability

Gross Margin
BLCO
59.45%
LNTH
61.1%
Operating Margin
BLCO
6.25%
LNTH
19.07%
Profit Margin
BLCO
-6.13%
LNTH
15.15%
ROE
BLCO
-4.5%
LNTH
21.45%
ROA
BLCO
0.53%
LNTH
9.28%

Growth

Revenue Growth
BLCO
7.1%
LNTH
4.0%
Earnings Growth
BLCO
--
LNTH
--

Financial Health

Debt/Equity
BLCO
0.76
LNTH
0.57
Current Ratio
BLCO
1.51
LNTH
2.7
Quick Ratio
BLCO
0.74
LNTH
2.2

Dividends

Dividend Yield
BLCO
--
LNTH
--
Payout Ratio
BLCO
0.0%
LNTH
0.0%

AI Verdict

BLCO BEARISH

The Advanced Deterministic Scorecard reveals severe financial health concerns with a Piotroski F-Score of just 2/9, indicating weak operational and balance sheet performance. Despite a reasonable Price/Book of 0.94 and a Debt/Equity ratio of 0.76, the company is unprofitable with a negative ROE of -4.50% and a profit margin of -6.13%. Earnings have collapsed year-over-year (-147.1%) and the last four quarters missed estimates by an average of -154.31%, signaling deteriorating fundamentals. While revenue growth of 7.10% and a gross margin above 59% provide some operational strength, the persistent earnings deterioration and lack of profitability undermine valuation support.

Strengths
Revenue growth of 7.10% YoY indicates top-line resilience in the medical instruments sector
Strong gross margin of 59.45% reflects pricing power and cost control in core operations
Debt/Equity ratio of 0.76 is below sector average of 2.69, suggesting conservative leverage
Risks
Piotroski F-Score of 2/9 signals severe financial distress and weak profitability trends
Negative ROE (-4.50%) and negative profit margin (-6.13%) indicate ongoing unprofitability
Earnings have collapsed with YoY EPS growth of -147.1% and Q/Q decline of -214.3%
LNTH NEUTRAL

LNTH exhibits strong operational health with a Piotroski F-Score of 7/9 and robust liquidity (Current Ratio 2.70), though it lacks an Altman Z-Score for bankruptcy benchmarking. While the company is highly profitable with an ROE of 21.45% and a consistent track record of earnings beats, the stock trades at a significant premium to its Graham Number ($35.98) and Intrinsic Value ($23.87). The bullish outlook is supported by a low Forward P/E of 12.81 and a positive analyst target of $91.38, but the current price is disconnected from deterministic value metrics.

Strengths
Strong financial health indicated by a Piotroski F-Score of 7/9
Excellent liquidity with a Current Ratio of 2.70 and Quick Ratio of 2.20
High profitability with 21.45% ROE and 61.10% Gross Margin
Risks
Significant valuation gap between current price ($80.59) and Graham Number ($35.98)
Modest year-over-year revenue growth of only 4.00%
Bearish technical trend (0/100) despite recent 6-month recovery

Compare Another Pair

BLCO vs LNTH: Head-to-Head Comparison

This page compares Bausch + Lomb Corporation (BLCO) and Lantheus Holdings, Inc. (LNTH) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile